N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinea CAS 152460-10-1 Imatinib Mesylate Yepakati Yakanyanya Kuchena

Tsanangudzo Pfupi

Zita: N-(5-Amino-2-methylphenyl) -4-(3-pyridyl) -2-pyrimidinea

Synonyms: Imatinib Mesylate Intermediate

CAS: 152460-10-1

Chitarisiko: Chiedza cheOrenji kuenda kuYero Powder kuenda kuCrystal

Kuchena: ≥98.0% (HPLC)

Pakati peImatinib Mesylate (CAS: 220127-57-1) mukurapa kwePhiladelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph + CML)

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Tsanangudzo:

Chemical Properties:

Chemical Name N-(5-Amino-2-methylphenyl) -4-(3-pyridyl) -2-pyrimidinea
Mashoko anoreva zvakafanana Imatinib Mesylate Intermediate;2-(5-Amino-2-methylanilino)-4-(3-pyridyl)pyrimidine
Nhamba yeCAS 152460-10-1
Nhamba yeCAT RF-PI230
Stock Status MuStock, Kugadzirwa Kunokwira Kusvika Matani
Molecular Formula C16H15N5
Molecular Weight 277.32
Melting Point 133.0-135.0℃
Brand Ruifu Chemical

Zvinotsanangurwa:

Item Zvinotsanangurwa
Chitarisiko Chiedza cheOrenji kuenda kuYero Powder kuenda kuCrystal
Kuchena / Analysis Method ≥98.0%
Kurasika paKuomesa ≤0.50%
Residue pamoto ≤0.50%
Zvose Zvisina Kuchena ≤2.0%
Maximum Single Kusachena ≤1.0%
Heavy Metals ≤20ppm
Test Standard Enterprise Standard
Usage Pakati peImatinib Mesylate (CAS: 220127-57-1)

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, Cardboard dhiramu, 25kg/Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza, mwando uye tumbuyu.

Zvakanakira:

1

FAQ:

Application:

Shanghai Ruifu Chemical Co., Ltd ndiyo inotungamira mugadziri uye mugovera weN-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinea (CAS: 152460-10-1) ine mhando yepamusoro. .
N-(5-Amino-2-methylphenyl) -4-(3-pyridyl)-2-pyrimidinea (CAS: 152460-10-1) iri pakati kazhinji mukugadzirwa kweImatinib Mesylate (CAS: 220127-57-1) API.
Imatinib mesylate imorekuru diki rinodzivirira c-Abl protein-tyrosine kinase, kinase inonyanya kukosha pakupararira kwechronic myelogenous leukemia (CML).Chiitiko chekufambisa pakati pemakromosomes 9 ne22 chinoburitsa chromosome yePhiladelphia, iyo inobva yagadzira Bcr-Abl fusion protein ine aberrant kinase chiitiko chinosimudzira kukurumidza kuwanda kwesero.Imatinib mesylate inosunga iyi yakakosha kinase, inomisa CML ine chekuita nekukura.Imatinib mesylate yakaramba ichiratidzwa kuti inhibit PDGFR uye tyrosine kinases yakabatana ne c-Kit.Magadzirirwo ane Imatinib mesylate akashandiswa mukurapa kwakasiyana kenza.
Imatinib mesylate is A tyrosine kinase inhibitor.Yakanyanya kutsanangurwa yeBCR-ABL, iyo enzyme inosanganiswa neasingaperi myelogenous leukemia (CML) uye mamwe mafomu eacute lymphoblastic leukemia (ALL).Iyo ine simba uye inosarudza v-Abl tyrosine kinase inhibitor (IC50 = 38 nM).Zvakare inhibits PDGFR uye c-kit.Inoratidza kusarudza kwev-Abl pamusoro peimwe tyrosine uye serine/threonine protein kinases.Inosarudza inodzivisa PDGF-inosimudzira kukura kwev-abl-yakashandurwa PB-3 masero uye v-sis-yakashandurwa BALB / c 3T3 masero mu vitro.Inoratidza antitumor mhedzisiro mumakonzo ane AMuLV kana BABL/c 3T3 v-sis masero.Inodzivisa kudzokorora kweSARS-CoV uye MERS-CoV in vitro (EC50 kukosha ndeye 9.823 uye 17.689 μM, zvichiteerana).

Nyora meseji yako pano ugotitumira